What Is KPV?

Sequence composition and structural identity

KPV is a minimal tripeptide sequence consisting of 3 residues: lysine (positively charged, with an amino group in its side chain), proline (a cyclic amino acid that constrains backbone conformation due to its pyrrolidine ring), and valine (a hydrophobic residue with a branched aliphatic side chain). The sequence represents the C-terminal residues 11-13 of alpha-melanocyte-stimulating hormone, a 13-residue neuropeptide. The molecular formula is C14H26N4O3, with a molar mass of approximately 286 g/mol, making it one of the smallest bioactive peptide sequences studied in biochemical research.Review · PMID 11268347

The tripeptide was identified through systematic fragmentation studies examining which structural elements of the parent peptide retain bioactivity in cultured cell-based assays. The minimal nature of the KPV sequence makes it a simplified molecular model for investigating receptor recognition and signaling-pathway mechanisms. The three-residue architecture constrains the peptide to discrete conformational states compared to longer peptide sequences.Review · PMID 11268347

Receptor interactions in cultured cell systems

KPV engages melanocortin receptors in cultured cell systems expressing these receptor proteins. In-vitro receptor-binding characterization employs cultured cells transfected with receptor genes, where binding is measured through radioligand displacement assays, fluorescence-based binding assays, and measurement of receptor-mediated signaling activation. These cultured-cell assays measure the tripeptide's capacity to compete for the same receptor-binding sites as the full-length alpha-melanocyte-stimulating hormone parent molecule.Review · PMID 10725812

Cell-based signaling studies characterize KPV-associated activation of downstream signaling pathways in cultured cell lines. Gene-expression changes and biochemical measurements of signaling proteins are assessed via quantitative reverse-transcription polymerase chain reaction, immunofluorescence, and protein quantification assays in defined cell populations. The signaling cascades downstream of KPV-receptor binding include second-messenger pathways and transcription-factor activation, characterized through standard molecular biology techniques in cultured systems.Review · PMID 11268347

Analytical characterization and chemical identity

KPV is characterized through high-performance liquid chromatography (HPLC) and mass spectrometry to establish chemical identity and purity for research applications. The tripeptide is analyzed via reversed-phase HPLC with UV detection at 214 nm, providing chromatographic separation and quantification of synthetic KPV. A stability-indicating HPLC method has been developed for KPV quantification in aqueous solutions, utilizing a reversed-phase C18 column with gradient mobile-phase elution and detection by UV absorbance.In vitro · PMID 29953505

Mass spectrometry analysis provides precise determination of molar mass and confirms the amino acid composition of synthetic KPV. The relatively simple tripeptide structure produces characteristic mass spectrometry fragmentation patterns. Under stress conditions—including acidic, alkaline, and oxidative environments—KPV yields degradation products that can be separated and identified via chromatographic and spectrometric methods, enabling characterization of the peptide's chemical stability profile.In vitro · PMID 29953505

Structural modification and analog synthesis

Structurally modified KPV analogs have been synthesized and characterized in in-vitro systems. A glycomimetic approach has been employed to modify the lysine residue through reductive alkylation with glucose derivatives, creating KPV analogs with altered chemical structure. These modified peptides are characterized via standard chemical and biochemical analytical methods to document structural changes and compare their properties to unmodified KPV.In vitro · PMID 29953505

Chemical modification studies assess how structural changes to the KPV sequence affect peptide properties, such as resistance to enzymatic degradation in cell-free systems. Modified KPV analogs are tested for proteolytic stability in in-vitro assays using purified proteolytic enzymes. These studies demonstrate that certain structural modifications can confer greater resistance to peptide-degrading enzymes compared to the unmodified tripeptide.In vitro · PMID 29953505

Cellular signaling modulation in cultured hepatocytes

KPV characterization in cultured hepatocyte cell lines (such as HepG2 cells) demonstrates signaling-pathway modulation measured through standard molecular biology techniques. In cultured hepatic epithelial cells, KPV modulates signaling cascades related to lipid metabolism and cellular stress responses, including pathways involving reactive oxygen species production and transcription-factor phosphorylation. These measurements are quantified through gene-expression quantification, phosphorylation assays, and metabolic measurements in defined cultured-cell systems.In vitro · PMID 42064835

The signaling responses measured in cultured hepatocytes include modulation of mitogen-activated protein kinase phosphorylation, changes in transcription-factor phosphorylation state, and altered gene-expression patterns. These cellular responses are quantified through immunological assays, reverse-transcription polymerase chain reaction, and enzyme-linked immunosorbent assays in cultured cells. The specificity and magnitude of these signaling measurements are assessed in cultured hepatocyte systems without intact tissue architecture or organism-level physiology.In vitro · PMID 42064835

KPV-mediated modulation of reactive oxygen species production and mitochondrial function in cultured cells provides a model for investigating the tripeptide's interaction with oxidative-stress pathways. Cultured hepatocytes exposed to KPV show measurable changes in reactive oxygen species levels quantified through fluorescent probes and spectroscopic detection. The downstream signaling consequences include activation or inhibition of protective pathways, which are characterized through measurement of signaling-protein phosphorylation and gene-expression changes.In vitro · PMID 42064835

Protease stability and degradation characterization

The susceptibility of KPV to enzymatic degradation has been characterized in cell-free biochemical assays using purified proteolytic enzymes. Short peptides such as KPV are particularly susceptible to exopeptidase activity, which cleaves amino acids sequentially from the peptide termini. In-vitro degradation studies quantify the rate of KPV cleavage under defined conditions, providing information about the peptide's structural stability in different chemical and enzymatic environments.In vitro · PMID 29953505

Chemical modification strategies aim to confer greater resistance to enzymatic degradation, allowing investigation of structure-activity relationships in the context of peptide stability. Structural analogs created through glycoalkylation or other chemical derivatization are compared to unmodified KPV for their relative susceptibility to proteolytic degradation. These comparative degradation studies employ standardized in-vitro assay conditions with purified proteases, enabling quantification of how chemical modifications affect the rate of peptide cleavage.In vitro · PMID 29953505

The studies at a glance

Representative in-vitro biochemical and analytical studies of KPV characterization.

Frequently asked questions